Holen Sie sich die Stockscreener-App
62.93
0.64%
0.40
Baxter International Inc Aktie (BBAX) Neueste Nachrichten
Analysts Offer Insights on Healthcare Companies: InflaRx (IFRX) and Baxter International (BAX) - The Globe and Mail
Why Baxter (BAX) Stock Is Up Today - Yahoo Finance
BAXTER ISSUES VOLUNTARY NATIONWIDE RECALL OF CEFAZOLIN IN DEXTROSE INJECTION, USP, 2G / 100ML (20MG / ML) SINGLE-DOSE INFUSION BAG IN 100ML DUE TO PARTICULATE MATTER FOUND IN SOLUTION - Solomon's Words for the Wise
Baxter International Inc (BAX) Shares Surge 4.2% -- What GF Scor - GuruFocus
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter International Q2 2026 Earnings Preview — July 30, Street Expects $0.37 EPS - AlphaStreet
TD Cowen Adjusts Price Target on Baxter International to $24 From $20, Maintains Hold Rating - Moomoo
BAX|Baxter International Inc|Price:23.335|Chg%:+0.935 - TradingKey
Baxter International Inc (BAX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Baxter International Inc (BAX) Cash Flow - TradingKey
Baxter International Inc (BAX) Income Statement - TradingKey
BAX|Baxter International Inc|Price:22.400|Chg%:+0.720 - TradingKey
Baxter International Inc (BAX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Baxter International Inc (BAX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bank of New York Mellon Corp Reduces Holdings in Baxter International Inc. $BAX - MarketBeat
A Look at Baxter International Inc (BAX) After 3.4% Gain -- GF V - GuruFocus
Will Baxter's Q2 Results Continue to Reflect Operational Headwinds? - Yahoo Finance
Baxter stock trades steadily as spin-off and transformation reshape earnings profile - Ad-hoc-news.de
Baxter International Inc (BAX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Earnings Preview: Baxter International (BAX) Q2 Earnings Expected to Decline - Yahoo Finance
Baxter International (BAX) Projected to Release Earnings on Thursday - MarketBeat
Baxter International stock trades steadily as spin-off plans follow mixed 2023 results - Ad-hoc-news.de
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Baxter stock trades steady as spin-off and portfolio reshaping shift focus toward margins - Ad-hoc-news.de
Baxter International stock trades steadily as core therapies support earnings and spin-off integrati - Ad-hoc-news.de
Baxter International Inc. stock underperforms Monday when compared to competitors - MarketWatch
Baxter stock remains supported by its latest reported results - Ad-hoc-news.de
Baxter International stock trades steadily as spin-off and cost actions reshape earnings profile - Ad-hoc-news.de
Baxter International stock trades steady as spin-off of kidney care business and margin focus shape - Ad-hoc-news.de
Baxter: The Chart Points Higher, Valuation And Growth Are Less Appealing - Seeking Alpha
Baxter International Appoints Michael Lemberger as Director of People Analytics - hrtoday.in
Baxter International stock trades steadily as spin-off and portfolio reshaping reshape earnings prof - Ad-hoc-news.de
Baxter International (BAX) Q4 2024 earnings summary - Quartr
Is Baxter International Inc (BAX) a Bargain After 3.2% Drop? GF Value Says Undervalued - GuruFocus
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Baxter stock trades steady as spin-off and earnings reshape the profile - ad-hoc-news.de
Sumitomo Mitsui Trust Group Inc. Cuts Holdings in Baxter International Inc. $BAX - MarketBeat
Baxter International Inc. (NYSE:BAX) Given Average Rating of "Reduce" by Analysts - MarketBeat
Baxter International Inc. Stock Climbs 5.4%, Outperforms Peers - webull.com
Baxter International's Q2 2026 earnings: What to expect - MSN
Baxter stock holds steady as restructuring and spin-off reshape the portfolio - Ad Hoc News
Is Now the Time to Add Singapore ETFs to Your Portfolio? - TradingView
Is Baxter’s Class I Respiratory Device Recall Reshaping the Investment Case for Baxter International (BAX)? - Sahm
Baxter International Updates Segment Reporting Structure and Metrics - The Globe and Mail
How Baxter International Inc. (BAX) Affects Rotational Strategy Timing - Stock Traders Daily
Q2 EPS Forecast for Baxter International Lowered by Analyst - MarketBeat
Baxter International (BAX) Announces Recast of Financial Reporti - GuruFocus
BBAX ETF Profile: Dividends, Returns (CBOE:BBAX) - TradingView
A Look at Baxter International Inc (BAX) After 3.4% Decline -- G - GuruFocus
Supply Chain Innovation Delivers More Nimble, Efficient Solutions - Baxter
Baxter International Inc. stock outperforms competitors despite losses on the day - MarketWatch
Baxter reorganizes to two segments, recasts prior-period segment results and discloses operational/organic sales metrics - TradingView
Baxter (NYSE: BAX) recasts 2025 segment sales and shows $505M loss - Stock Titan
Goldman Sachs Adjusts Price Target on Baxter International to $21 From $19, Maintains Neutral Rating - Moomoo
Baxter International Streamlines Reporting Segments to Two Units, Revises Historical Financials Starting Q2 2026 - Kalkine Media
ETFs Investing in CLP Holdings Limited Stocks - TradingView
ETFs Investing in Baxter International Inc. Stocks - TradingView
ETFs Investing in Origin Energy Limited Stocks - TradingView
Avoiding Lag: Real-Time Signals in (BBAX) Movement - Stock Traders Daily
Baxter stock reflects a diversified medical technology business - Ad-hoc-news.de
Baxter International stock reflects a diversified medical portfolio and ongoing portfolio transforma - Ad Hoc News
Press Release: Baxter to Host Second-Quarter 2026 Financial Results Conference Call for Investors - Moomoo
Baxter to Host Second-Quarter 2026 Financial Results Conference Call for Investors - Business Wire
Retia Medical Adds Former Baxter Executive Christopher Benassi to Advisory Board - citybiz
Baxter Beats Stable Value Fund 401(k) Plan Suit, For Good - Law360
A Look at Baxter International Inc (BAX) After 3.9% Decline -- G - GuruFocus
Baxter International balances portfolio focus and steady operations - Ad Hoc News
Baxter International focuses on core medical technologies as investors watch US healthcare demand - Ad Hoc News
0.62%
0.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):